CDY 1.43% 7.1¢ cellmid limited

It could also be viewed that income has increased year on year...

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 3,001 Posts.
    lightbulb Created with Sketch. 91
    It could also be viewed that income has increased year on year for the last 5 years. The company has always been cashgkow negative at least during that time. This year they increased income again and reduced loss it appears. The downside is they still spend more than they earn but hopefully a lot of those costs can be put down to developing their markets in USA and China amongst others. It may take longer to become profitable but look on the bright side they are increasing income yearly mostly on the back of a product that i dont think they initially ever thought would become so big. They still have any and all of their other channels such as midkine to possibly come on line and generate further income on top of what they already have. Doesnt seem like the end of the world, although shame they couldnt get by without cr.

    I guess it boils down to the fact they never intended to be a hair care product supplier, they were more into medical research. They are still into medical research but in the meantime evolis grts yhem an additional 4-5 million a year and growing?? A good thing i would think. Without it imagine how the report would look.

    Not that big a deal predicting it would hit below .375 happens 90% of the time price goes to or below cr level.
    Last edited by andrewk65: 24/08/18
 
watchlist Created with Sketch. Add CDY (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.